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Summary 
 
 The objective was to determine the effects 
of L-carnitine on cell proliferation and on 
messenger RNA (mRNA) concentrations in 
the insulin-like growth factor (IGF) system.  
Cultured porcine embryonic myoblasts (PEM) 
were isolated from fetuses at mid-gestation 
from sows fed a common gestation diet with a 
50-g top dress of 0 (control, n = 6) or 100 mg 
of L-carnitine (n = 6).  Proliferation of PEM 
was evaluated at 36, 48, 60, and 72 h post-
plating.  Real-time quantitative PCR was used 
to determine growth factor mRNA concentra-
tions in culture.  The number of cells/cm2 did 
not differ (P>0.05) from sows fed either diet, 
but the number of cells/cm2 increased 
(P<0.05) between each time period.  There 
was a treatment × time interaction (P = 0.05) 
for number of doublings.  The number of dou-
blings was greater (P<0.01) between 36 and 
48 h for PEM isolated from dams fed L-
carnitine, compared with that of the controls.  
When PEM were incubated with L-carnitine 
(n = 4) at six concentrations (3.125, 6.25, 
12.5, 25, 50 and 100 µmol/L) and compared 
with a control, no proliferation differences 
were detected (P>0.05).  There was no treat-
ment difference (P>0.05) for the expression of 
IGF-I or insulin-like growth factor binding 
protein 5 (IGFBP-5).  But PEM isolated from 
sows fed L-carnitine had decreased (P<0.05) 
IGF-II, IGFBP-3, and myogenin (61, 59, and 
67%, respectively) mRNA concentrations 
compared with those of controls.  These data 
suggest that L-carnitine influences the IGF 
system and myogenin, resulting in enhanced 
proliferation and delayed differentiation of 
porcine embryonic myoblasts. These results 
show that L-carnitine plays a role in regulating 
proliferation and differentiation of cultured 
porcine embryonic myogenic cells and that 
fetal muscle growth and development could be 
increased by feeding L-carnitine. 
 
(Key Words:  Insulin-like Growth Factor, In-
sulin-like Growth Factor Binding Protein, L-
carnitine, Myoblasts, Pigs.) 
 
Introduction 
 
 The IGF system is complex, including 
growth factors, receptors, and binding pro-
teins, all of which are distinct gene products.  
The IGF-I and -II growth factors are important 
regulators of fetal and postnatal growth.  Both 
of these factors mediate cell proliferation, dif-
ferentiation, and metabolism in vivo and in 
vitro.  Research has reported that in porcine 
fetuses, IGF-I and -II were expressed and pro-
duced primarily in muscle cells, supporting 
the hypothesis that these growth factors modu-
late fetal muscle growth.  The IGF in serum 
are invariably found in association with IGF 
binding proteins (IGFBP), which serve as a 
storage reservoir, increase the half-life, and 
either inhibit or potentiate IGF actions.  In ad-
dition, the IGFBP have biological effects that 
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are independent of the two growth factors.  
Evidence of the IGF-independent action of 
IGFBP-3 was also reported in 1997; it was 
found that IGFBP-3 binds specifically to the 
type-V transforming growth-factor-β receptor.  
Proliferation of PEM is suppressed in the pres-
ence of IGFBP-3, and the amount of IGFBP-3 
mRNA is reduced concurrently with the ex-
pression of myogenin, suggesting that IGFBP-
3 also has a role in myogenic cell differentia-
tion.  At the initiation of C2 myoblast differ-
entiation, IGFBP-5 mRNA reportedly in-
creases, coinciding with the onset of myo-
genin.  In addition, in 2002, the IGF-
independent actions of IGFBP-5 were report-
edly attributed to localization of IGFBP-5 in 
the nucleus and IGFBP-5 membrane-bound 
receptors.  These data suggest that IGFBP can 
effect muscle growth and development at the 
local level, as well as have IGF-independent 
effects. 
 
 Kansas State University has previously 
reported that supplementing pigs with car-
nitine was beneficial for both growth traits and 
carcass muscling.  In a gestation study, it was 
found that supplementing dams with L-
carnitine increased circulating IGF-I concen-
trations at mid-gestation.  Other researchers 
determined that injecting L-carnitine into 
streptozotocin-induced diabetic rats increased 
serum carnitine concentrations, total serum 
and liver IGF-I concentrations, and expression 
of liver IGF-I mRNA.  L-carnitine had no ef-
fect on IGF-II concentrations or IGF-II 
mRNA. 
 
 It has long been established that the trans-
port of long-chain fatty acids across the mito-
chondrial membrane into the mitochondrial 
matrix where β-oxidation occurs is L-
carnitine-dependent.  To our knowledge, how-
ever, there is no data representing how sow 
supplementation with L-carnitine affects PEM 
and the expression of IGF-system mRNA.  In 
this experiment, L-carnitine was fed to gestat-
ing sows, and PEM were isolated from fetuses 
at mid-gestation.  The main goal of this study 
was to use an in vitro model (PEM) to deter-
mine if there is a direct or indirect effect of L-
carnitine on embryonic cell proliferation and 
if mRNA concentrations of the IGF-system 
are affected. 
 
Procedures 
 
 Animals and Feeding Protocol.  Twelve 
fourth-parity sows (PIC, Franklin, KY; C 22 
sows; BW = 552.7 lb) were artificially in-
seminated (PIC; 327 MQ) 12, 24, and 36 h 
after the onset of estrus.  Sows were randomly 
allotted to one of two dietary treatments.  All 
sows were fed once daily 4.4 lb of a gestation 
diet based on corn-soybean meal (Table 1) and 
received a 50-g top dress containing either 0 
(control, n = 6) or 100 mg of L-carnitine 
(Carniking 10; 10% L-carnitine; Lonza, Inc., 
Fairlawn, NJ) from d 1 to 54.5 of gestation.  
Day 1 of gestation was considered 12 h after 
the first insemination.  Sows were allowed ad 
libitum access to water. 
 
Table 1.  Composition of Diet (As-fed Basis) 
Item 
Gestation 
Diet, % 
Corn 85.06 
Soybean meal (47% CP) 10.89 
Mono-calcium phosphate 1.85 
Limestone 1.05 
Salt 0.50 
Minerals and vitamins 0.65 
 100.0 
Calculated Analysis, %  
   Lysine 0.55 
   Crude protein 12.30 
   ME, Mcal/lb 1.50 
   Calcium 0.80 
   Phosphorus 0.70 
   Fat 3.64 
   Fiber 1.67 
 
 Eighteen hours before hysterectomy, sows 
were transported from Kansas State University 
Swine Teaching and Research Center to the 
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surgery suite on campus where sample collec-
tions were performed 24 h after the last feed-
ing.   
 
 A hysterectomy was completed on each 
sow between d 55 and 59 of gestation.  Sows 
were anesthetized and the uterus was re-
moved. Once the uterus was removed, the 
muscle layers and skin were closed with ab-
sorbable sutures.  Fetal pigs were immediately 
removed under aseptic conditions and rapidly 
transported to a laminar flow hood where my-
ogenic cells were isolated.  Isolated cells were 
suspended in solution, frozen at -80°C, and 
stored in a liquid nitrogen tank. 
 
 Cell Culture.  Proliferation rates of the 
porcine embryonic myoblasts isolated from 
each of the sows were determined at 36, 48, 
60 and 72 h post-plating.  Growth factor and 
myogenin mRNA concentrations were deter-
mined from the same breakouts, at 96 h post-
plating. 
 
 To establish cultures from frozen stocks, 
rapidly thawed cell suspensions were diluted 
with 25 mL of Dulbecco’s Modified Eagle 
Medium containing 10% (v/v) fetal calf se-
rum.  One mL and 10 mL of cell solution were 
plated on 4-well plates (2-cm2-wells) and 100-
mm dishes, respectively, coated with Base-
ment Membrane Matrigel (diluted 1:27 (v/v) 
in DMEM.  All cultures were maintained at 
37°C, 5% CO2, 95% air in a water-saturated 
environment.  After a 24-h attachment period, 
the 100-mm plates were rinsed twice with 5 
mL of DMEM.  Plates were refed with 
DMEM containing 10% FCS (0.5 mL/2-cm2 
well or 7 mL/100-mm plate).  At the desired 
post-plating time, [3H]thymidine (1 µCi/mL 
final concentration; NEN Life Science, Bos-
ton, MA) was added to the culture media on 
the 4-well plates and allowed to incubate at 
37°C for 3 h.  After radioisotope exposure, 
cells were rinsed three times with 0.5 mL cold 
DMEM, and 5% cold trichloroacetic acid 
(TCA) was added.  Four random microscope 
fields were counted and averaged for each 
well to determine the number of PEM.  Plates 
were incubated at 4°C overnight and then 
rinsed again with cold TCA.  [3H]thymidine 
incorporation into cellular DNA was measured 
by dissolving cell material in 0.5 mol/L so-
dium hydroxide and counting in a scintillation 
counter.  All data were averaged from tripli-
cate wells. 
 
 Direct Effects of L-carnitine on PEM In 
Vitro.  A separate set of experiments evaluat-
ing the range of 3.125 to 100 µmol/L L-
carnitine were undertaken to determine any 
potential direct effects of L-carnitine on PEM.  
To establish cultures from frozen stocks, the 
same procedure as previously described was 
followed, with differences being 1-mL of cell 
solution was plated on a 24-well plate (2-cm2 
wells) coated with Basement Membrane Ma-
trigel (diluted 1:27 (v/v) in DMEM).  After a 
24-h attachment period, the wells were aspi-
rated and refed with 0.5 mL DMEM contain-
ing 10% FCS.  At 48-h post-plating, the wells 
were rinsed three times with 0.5 mL DMEM, 
and 0.5 mL of desired test media was added to 
each well.  To make stock solutions, L-
carnitine was dissolved in DMEM.  The L-
carnitine stock solutions were diluted with 
DMEM containing low serum (2% v/v swine 
serum) to make test media (3.125, 6.25, 12.5, 
25, 50, and 100 µmol/L).  In addition, a con-
trol media was made with DMEM replacing 
the addition of a L-carnitine stock solution.  
At 72 h post-plating, the wells were incubated 
for 3 h with [3H]thymidine.  The remaining 
steps of the radioisotope exposure were com-
pleted as described previously.  All data points 
were averaged from triplicate wells. 
 
 Isolation of RNA and Real-time Quanti-
tative PCR.  At 96-h post-plating, total RNA 
was isolated from cells on the 100-mm plates.  
The concentration of RNA was determined by 
absorbance at 260 nm.  TaqMan reverse tran-
scription reagents and MultiScribe Reverse 
Transcriptase were used to produce compli-
mentary DNA (cDNA) from 1 µg of total 
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RNA.  Random hexamers were used as prim-
ers in cDNA synthesis.  
 
 Real-time quantitative PCR was used to 
measure the quantities of IGF-system mRNA, 
relative to the quantity of 18S ribosomal RNA 
(rRNA) in total RNA isolated from cultured 
cells.  Measurement of the relative quantity of 
cDNA was carried out by using TaqMan Uni-
versal PCR Master Mix, 900 nmol/L of the 
appropriate forward and reverse primers, 200 
nmol/L of appropriate TaqMan detection 
probe, and 1 µl of the cDNA mixture.  The 
porcine-specific forward and reverse primers 
and TaqMan detection probes were synthe-
sized according to published GenBank se-
quences for the specific genes of interest.   
 
 Relative quantities of target mRNA were 
normalized to 18S rRNA with the eukaryotic 
18S rRNA endogenous control.  Assays were 
performed in an ABI Prism 7000 sequence 
detection system, using thermal cycling pa-
rameters recommended by the manufacturer 
(50 cycles of 15 s at 95ºC and 1 min at 60ºC).  
Relative expression of the porcine genes was 
normalized with the 18S endogenous control 
by using the ∆-CT method, and is expressed in 
relative units.  Titration of 18S, IGF-I, IGF-II, 
IGFBP-3, IGFBP-5, and myogenin primers 
against increasing amounts of cDNA gave lin-
ear responses with slopes of -3.3 to -3.9. 
 
 Statistical Methods.  A single-factor (0 or 
100 mg of L-carnitine) experiment in a com-
pletely randomized design was conducted.  
Statistical analyses for cell-proliferation data 
and gene-expression levels were performed 
with the Mixed procedure of SAS, with the 
dam as the experimental unit.  The statistical 
model for the proliferation data included the 
fixed effects of treatment and time and the 
random effect of animal.  The statistical model 
for the gene-expression data included the 
fixed effect of treatment and the random effect 
of animal.  The Mixed procedure of SAS was 
also used for the analysis of the PEM L-
carnitine titration experiment, and the L-
carnitine concentration was the fixed effect 
with assay as the random effect.  All main-
effect and interaction means were separated 
(P<0.05), unless otherwise noted, by using the 
Least Significant Difference procedure when 
the respective F-tests were significant. 
 
Results and Discussion 
 
 To determine the effect of feeding L-
carnitine to gestating sows, plasma L-carnitine 
concentrations were determined.  At mid-
gestation, circulating total carnitine was 30% 
greater (P<0.05) in the sows supplemented 
with L-carnitine compared with that of the 
control sows (27.20 and 20.97 µmol/L, re-
spectively).  This indicates that supplemental 
L-carnitine increases circulating carnitine con-
centrations. 
 
 The average number of cells/cm2 did not 
differ (P>0.05) between PEM from sows fed a 
control diet or fed a diet with supplemental L-
carnitine (Figure 1, Panel A); as expected, 
however, there was a time effect (P<0.05).  As 
the number of hours post-plating increased, 
the average number of cells/cm2 also in-
creased (P<0.05) between each of the evalu-
ated time-periods.  At the conclusion of the 
experiment (72 h), there were 11% more cells 
in the L-carnitine treatment than in the con-
trol. 
 
 An indicator of PEM proliferation is the 
rate of [3H] incorporation.  Incorporation of 
[3H]thymidine/cell was not altered (P>0.05) 
by treatment at 36, 48, 60, or 72 h post-plating 
(Figure 1, Panel B).   
 
 There was a treatment x time interaction 
(P = 0.05) for the number of doublings (Figure 
1, Panel C).  There was a 1.5-fold increase 
(P<0.01) in the number of doublings between 
36 and 48 h for the PEM isolated from dams 
fed L-carnitine, compared with the number of 
doublings in PEM from control dams.  At the 
remaining time intervals of 48/60 and 60/72 h, 
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there were no differences (P>0.05) detected 
between the two treatments. 
 
 Porcine embryonic myoblasts isolated 
from a commercial gilt fed a diet containing 
no supplemental L-carnitine were used to 
evaluate the direct effects of L-carnitine.  No 
differences (P>0.05) were observed for the 
percentage change in counts per minute be-
tween the six L-carnitine concentrations and 
the control (Figure 2). 
 
 Total RNA was isolated from the PEM 
cultures at 96 h post-plating.  The expression 
of IGF-I, IGF-II, IGFBP-3, IGFBP-5, and 
myogenin mRNA were determined (Table 2).  
There was no difference (P>0.05) between 
treatments for the expression of IGF-I or 
IGFBP-5.  But PEM isolated from sows fed L-
carnitine had decreased (P<0.05) mRNA con-
centrations of IGF-II, IGFBP-3, and myogenin 
(61, 59, and 67%, respectively) compared with 
those of PEM isolated from control sows.  
 
 Little is known about the effects of L-
carnitine on the IGF system in primary por-
cine muscle cell cultures.  Two different mod-
els were used to determine the direct and indi-
rect effects of L-carnitine on PEM prolifera-
tion.  A diet with no supplemental L-carnitine 
was fed to a gilt, and then PEM were isolated 
from fetal muscle and used to determine the 
direct effects of adding L-carnitine in vitro.  
The indirect effects of L-carnitine were evalu-
ated by isolating PEM from sows either sup-
plemented with L-carnitine or fed a control 
diet during gestation.  The increased concen-
trations of circulating L-carnitine in the gestat-
ing sows supplemented with L-carnitine sug-
gests that the L-carnitine is being absorbed 
and entering the blood stream.  Previous re-
search at Kansas State University also ob-
served that sows supplemented with L-
carnitine had increased concentrations of cir-
culating carnitine. 
 
 At the initiation of the experiment, there 
was not a treatment difference in the number 
of cells at 36 h.  At each succeeding time in-
crement, however, a numerical increase was 
observed for the number of PEM isolated from 
sows supplemented with L-carnitine and there 
were 11% more cells in the L-carnitine treat-
ment than the control at 72 h.  In support of 
the increased number of cells at the conclusion 
of the experiment, there was a 1.5-fold in-
crease in the number of doublings between 36 
and 48 h post-plating in the L-carnitine cells, 
compared with the number of doublings in 
cells from the controls. This suggests that 
PEM isolated from sows fed L-carnitine have 
an initial increased rate of proliferation and 
that this alteration in proliferation early during 
the culture period is resulting in numerical in-
creases in total cells at the conclusion of pro-
liferation.  These data support earlier reports 
that offspring from dams supplemented with 
L-carnitine had a larger cross-sectional area in 
the semitendinosus muscle.  A concern with 
primary cultures is that non-myogenic cell 
types, which could have shorter doubling 
times, are present and can make interpretation 
of proliferation data difficult.  Results of the 
differentiation studies (data not shown) sug-
gest that the changes in cell proliferation were 
a result of treatment affecting only myogenic 
cells, indicating that the increased rate of pro-
liferation in cultures derived from L-carnitine 
is not due to the potential for greater prolifera-
tion of non-myogenic cells overtaking these 
cultures. 
 
 Even though there was not a treatment ef-
fect, the uptake of [3H]thymidine in the PEM 
isolated from sows supplemented with L-
carnitine continued to increase up to 60 h 
post-plating, but only up to 48 h in the control 
cultures.  At the last evaluated time (72 h), a 
numerically greater uptake of [3H]thymidine 
remained in the L-carnitine cultures.  This is 
consistent for the observed numerical increase 
in number of cells in the L-carnitine cultures 
compared with the number of cells in the con-
trols at the end of the assay. 
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 To determine if the effects of L-carnitine 
on the proliferation data were a direct effect of 
L-carnitine, another experiment using PEM 
isolated from a commercial pregnant gilt was 
conducted by incubating the PEM with differ-
ing L-carnitine concentrations.  At the six L-
carnitine concentrations evaluated, no consis-
tent differences between the concentrations 
and the control were found for the incorpora-
tion of  [3H]thymidine into the PEM.  There 
was no trend amongst the L-carnitine concen-
trations for [3H]thymidine incorporation.  This 
indicates that L-carnitine is most likely not 
directly affecting the proliferation of the PEM, 
and that the increased number of doublings 
from the L-carnitine treatment is a result of an 
indirect effect.  Another explanation comes 
from a previous study in which it was reported 
that human skeletal muscle in culture had two 
different affinities for carnitine uptake: a high-
affinity uptake between 0.5 and 10 µmol/L 
and a low-affinity uptake between 25 and 200 
µmol/L carnitine.  Therefore, in the current 
study, the lack of a trend between the prolif-
eration rate of the PEM and the L-carnitine 
concentration may be caused by the differing 
affinities for carnitine uptake by the PEM. 
 
 The effect of feeding L-carnitine on car-
cass muscle characteristics has been studied 
extensively.  Research has reported that feed-
ing sows 100 mg/d of L-carnitine resulted in a 
90% increase in maternal circulating IGF-I 
concentration at mid-gestation compared with 
that of control sows.  But little is known about 
the interactive effects of L-carnitine and the 
growth factors or about the singular effects of 
L-carnitine on porcine fetal muscle growth 
and development.  It was hypothesized that L-
carnitine may be influencing the IGF system.  
Many cell types, including myogenic cell 
lines, have been shown to synthesize both IGF 
and IGFBP.  Previous studies have identified 
that multiple components of the IGF system 
affect the proliferation and differentiation of 
PEM.  In the current study, growth factor, 
binding protein, and myogenin mRNA con-
centrations were determined in PEM at 96 h in 
culture.  Even though not significant, the ex-
pression of IGF-I was increased 82% in PEM 
isolated from dams supplemented with L-
carnitine, compared with expression in non-
supplemented sows.  High concentrations of 
IGF-I increased [3H]thymidine incorporation 
into primary porcine cell cultures, and IGF-I 
has been shown to extend proliferation of 
muscle cells.  Therefore, the observed numeri-
cal increase of IGF-I mRNA in L-carnitine 
cultures suggests that L-carnitine increases 
local IGF-I production.  The increased IGF-I 
availability in the L-carnitine cultures explains 
why the rate of [3H]thymidine incorpora-
tion/cell continued to increase for an addi-
tional 12 h, compared with that of the con-
trols.  In addition, there was an accumulation 
of cyclin D1 (10-fold increase) by mid-G1 
phase of the cell cycle in satellite cells isolated 
from IGF-I transgenic mouse muscle, in com-
parison with accumulations in muscle from 
control littermates.  This suggests that IGF-I 
enhances the replicative life span of myogenic 
cells, which is also observed in the current 
study because of the increased doublings and 
the total number of cells at the end in the L-
carnitine cultures. 
 
 During fetal muscle development, the pro-
gression of events in myogenesis is that 
mononucleated proliferating myoblast exit the 
cell cycle and fuse to form multi-nucleated 
cells or myotubes.  Myoblasts withdrawal 
from the cell cycle activates transcription fac-
tors (MyoD family regulatory factors), with 
one being myogenin, which is expressed at the 
onset of myogenesis.  Myogenin is not ex-
pressed in proliferating myoblasts, but only 
under differentiation conditions, and is often 
used as an early marker of differentiation in 
muscle cell cultures.   
 
 In addition to the transcription factors, 
IGF-II has been found to modulate fetal 
growth and development.  Myoblasts them-
selves can secrete IGF-II, which can itself in-
duce differentiation, or IGF-II can promote 
differentiation through paracrine and endo-
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crine mechanisms.  In C2 myoblasts, IGF-II 
mRNA concentrations rise dramatically (4-
fold) during differentiation, compared with 
those expressed during proliferation. It is sug-
gested that the autocrine secretion of IGF-II is 
essential for the process of terminal differen-
tiation in these cells because the rate of differ-
entiation correlates with the level of expres-
sion of IGF-II.  In the current study, IGF-II 
mRNA concentrations were decreased 61% 
and myogenin was decreased 67% in L-
carnitine PEM, compared with those of the 
control PEM.  Taken together, the IGF-II and 
myogenin data suggest that there is a delay in 
the onset of terminal differentiation in PEM 
isolated from sows fed L-carnitine, thus allow-
ing these cells to remain in a proliferative 
stage longer.  Furthermore, the numerical dif-
ference in IGF-I mRNA would be consistent 
with cells having increased proliferative ca-
pacity. 
 
 The IGF binding proteins are known for 
their ability to bind growth factors to increase 
their stability and half-life, as well as to modu-
late the action of the growth factors.  In this 
study, the mRNA concentrations of IGFBP-3 
and IGFBP-5 were reduced 59% and 50%, 
respectively, in the PEM isolated from the 
sows supplemented with L-carnitine, com-
pared with their concentrations in the control 
sows.  This suggests that there would be less 
binding capacity in PEM from supplemented 
sows, and that the action of IGF-I may be en-
hanced, ultimately increasing cell prolifera-
tion.  The decrease in IGFBP-3 mRNA con-
centrations in L-carnitine cultures, compared 
with those of the controls, indicates that the L-
carnitine cultures were at the initiation of dif-
ferentiation at 96 h in culture.  It has been re-
ported that in extensively fused cultures (144 
h in culture) there was a three-fold increase in 
IGFBP-3 mRNA concentration, compared 
with that of the nonfused cultures.  This also 
supports the current proliferation data, that L-
carnitine cultures proliferate longer and, 
hence, would have lower IGFBP-3 mRNA 
concentrations. The decrease in the expression 
of IGFBP-5 in the PEM isolated from the L-
carnitine treatment also supports that there 
would be increased proliferation in this treat-
ment because IGFBP-5 is secreted within 12 h 
of the onset of differentiation in myoblasts 
(14) and is associated with terminal differen-
tiation.   
 
 We have shown that L-carnitine influences 
muscle growth through an indirect mecha-
nism, as evidenced by the prolonged prolifera-
tion and suppressed differentiation in the PEM 
isolated from  sows supplemented with L-
carnitine.  The increased proliferation rates 
and the 82% increase in IGF-I mRNA are re-
ported characteristics specific for myogenic 
cells.  The observed expression of EGFBP-3 is 
further evidence in the current study that the 
prolonged proliferation was not the result of 
contaminating non-myogenic cells because 
IGFBP mRNA is not produced by fibroblasts.   
 
 In summary, the enhanced IGF-I concen-
tration and decreased IGFBP-3 could potenti-
ate IGF-I actions on proliferation.  At the 
same time, IGF-II and myogenin mRNA con-
centrations are reduced, resulting in sup-
pressed differentiation.  These results, in com-
bination with the developmental pattern of the 
growth factors, show that L-carnitine plays a 
role in regulating proliferation and differentia-
tion of cultured porcine embryonic myogenic 
cells, and that fetal muscle growth and devel-
opment could be increased. 
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Figure 1  The Average Number of Cells per cm2 (panel A), [3H]thymidine Incorporation per Cell 
(panel B), and the Number of Doublings (panel C) at Designated Times Post-plating (36, 48, 60, 72 h 
post-plating) in Porcine Embryonic Myoblasts (PEM) Isolated from Dams Fed a Control Diet or 
Supplemented 100 mg/day of L-carnitine.  Values are means and SEM, n = 6 per treatment.  There was 
a treatment x time interaction (P = 0.05) for the number of doublings.  The number of doublings was 
greater (P < 0.05) between 36 and 48 h for the PEM isolated from dams fed L-carnitine, compared with 
those of the controls, and the asterisk indicates this difference. 
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Figure 2  The Effect of Differing Concentrations of L-carnitine in 2% Swine Serum (v/v) 
and Dulbecco’s Modified Eagle Medium on the Percentage Change of Counts per Minute 
in Comparison with those of the Control for Porcine Embryonic Myoblasts (PEM).  The 
PEM were incubated with the L-carnitine for 24 h, between 48 and 72 h post-plating.  Values are 
means and SEM, n = 4 per concentration.   
 
 
 
 
 
Table 2.  Growth-Factor Messenger RNA Content in Porcine Embryonic Muscle Cells at 
96 h of Culturea 
Gene Control L-carnitine SEM P-value 
IGF-I 
IGF-II 
IGFBP-3 
IGFBP-5 
Myogenin 
3.47 
21.68 
5.62 
22.49 
4.02 
6.31 
8.44 
2.30 
11.24 
1.33 
1.89 
3.54 
0.90 
4.85 
0.79 
0.31 
0.02 
0.03 
0.13 
0.04 
  aGene expression levels are expressed in relative units; n = 6 per treatment. 
